These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 9121238)

  • 41. [Epidemiological features of antibiotic resistance in Streptococcus pneumoniae strains isolated from patients with pneumococcal pneumonias].
    Martynova AV
    Probl Tuberk Bolezn Legk; 2007; (12):47-9. PubMed ID: 18326216
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The clinical impact of macrolide resistance in pneumococcal respiratory infections.
    Garau J
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S33-8. PubMed ID: 11574193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 44. Levofloxacin-resistant pneumococcus.
    Klugman KP
    Clin Infect Dis; 2000 Aug; 31(2):626-7. PubMed ID: 10987743
    [No Abstract]   [Full Text] [Related]  

  • 45. Susceptibility to selected antibiotics of Streptococcus pneumoniae and Streptococcus pyogenes strains isolated from patients with respiratory tract infections.
    Mazur E; Ligieza J; Niedźwiadek J; Polak G; Kozioł-Montewka M; Hencner Z
    Ann Univ Mariae Curie Sklodowska Med; 1999; 54():407-10. PubMed ID: 11205800
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of severe meningitis due to antibiotic-resistant Streptococcus pneumoniae.
    Hudson BJ; Havryk A; Abel SJ; Fernandes CJ
    Med J Aust; 1999 Oct; 171(8):447-8. PubMed ID: 10590755
    [No Abstract]   [Full Text] [Related]  

  • 47. Pneumonia caused by a pneumococcus resistant to erythromycin and lincomycin. Case report.
    Medoff G
    Mo Med; 1974 Aug; 71(8):496-7. PubMed ID: 4152480
    [No Abstract]   [Full Text] [Related]  

  • 48. Resistance of Streptococcus pneumoniae to fluoroquinolones--United States, 1995-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Sep; 50(37):800-4. PubMed ID: 11785571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Selective antibiotic pressure and resistance in infections by Streptococcus pneumoniae].
    Gómez-Lus R; Adrián F; Gómez-Lus S; Rubio-Calvo MC
    Med Clin (Barc); 1998 Feb; 110 Suppl 1():3-7. PubMed ID: 9717152
    [No Abstract]   [Full Text] [Related]  

  • 50. Treating respiratory tract infections in ambulatory care in Belgium: fluoroquinolone consumption and resistance development.
    Simoens S; Verhaegen J; Laekeman G; Peetermans WE
    Int J Antimicrob Agents; 2005 Jul; 26(1):62-8. PubMed ID: 15963695
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Pihlajamäki M; Kotilainen P; Kaurila T; Klaukka T; Palva E; Huovinen P;
    Clin Infect Dis; 2001 Aug; 33(4):483-8. PubMed ID: 11462184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antibiotic-resistant Streptococcus pneumoniae. Implications for medical practice.
    Wang EE; Kellner JD; Arnold S
    Can Fam Physician; 1998 Sep; 44():1881-8. PubMed ID: 9789668
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bacteremia and meningitis caused by a macrolide-sensitive strain of Streptococcus pneumoniae during treatment with azithromycin.
    Lisby G; Brasholt MS; Teglbjerg MS
    Clin Infect Dis; 2001 Aug; 33(3):415-6. PubMed ID: 11438918
    [No Abstract]   [Full Text] [Related]  

  • 54. Streptococcus pneumoniae: does antimicrobial resistance matter?
    Lynch JP; Zhanel GG
    Semin Respir Crit Care Med; 2009 Apr; 30(2):210-38. PubMed ID: 19296420
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Meningitis caused by multiresistant Pneumococcus].
    Alonso Palacio J; Madrigal Díez V; García Fuentes M
    An Esp Pediatr; 1992 Apr; 36(4):320-2. PubMed ID: 1605423
    [No Abstract]   [Full Text] [Related]  

  • 56. Quinolones and pneumococci.
    Tillotson GS; Peterson LR
    J Antimicrob Chemother; 2000 May; 45(5):709-10. PubMed ID: 10797099
    [No Abstract]   [Full Text] [Related]  

  • 57. The in vivo-in vitro paradox in pneumococcal respiratory tract infections.
    Bishai W
    J Antimicrob Chemother; 2002 Mar; 49(3):433-6. PubMed ID: 11864942
    [No Abstract]   [Full Text] [Related]  

  • 58. Pneumococcal infections.
    Durbin WJ
    Pediatr Rev; 2004 Dec; 25(12):418-24. PubMed ID: 15574538
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of pneumococcal infections in children].
    Olivier C; Gouraud F
    Ann Pediatr (Paris); 1989 Nov; 36(9):575-9. PubMed ID: 2589771
    [No Abstract]   [Full Text] [Related]  

  • 60. The clinical impact of resistance in the management of pneumococcal disease.
    Leggiadro RJ
    Infect Dis Clin North Am; 1997 Dec; 11(4):867-74. PubMed ID: 9421704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.